Buscar
03/11/2025
Independent, international validation of the unsupervised harmony classification of Acute Myeloid Leukemia
Turki, A, Dall'Olio, D, Carota, L, Polizzi, S, Morote, M, Della Porta, M, Zhao, YM, Lanino, L, Sobas, M, Zhao, YQ, Sanchez, AH, Eric, S, Gimenez, LT, Abáigar, M, Elicegui, JM, Ramiro, AV, Dohner, K, Tettero, J, Esteve, J, Martinez-Lopez, J, Metzeler, K, Haferlach, T, Lehmann, S, Pratcorona, M, Thiede, C, Versluis, J, Mecklenbrauck, R, Heuser, M, Benner, A, Huntley, B, Rivas, JMH, Ossenkoppele, G, Döhner, H, Castellani, G, Bullinger, L. Independent, international validation of the unsupervised harmony classification of Acute Myeloid Leukemia. BLOOD. 2025; 146DOI:10.1182/blood-2025-451. PMID:. IF:23.100(Q1/1D).
03/11/2025
Bone marrow alterations and clonal hematopoiesis in germline ETV6 mutation carriers without hematologic malignancy
Torres-Esquius, S, Gabarros-Subira, M, Gurnari, C, Bravo-Perez, C, López, GR, Arias, RD, Sanz, A, Martinez, MM, Beas, F, Jáuregui, SN, Arias, R, Canela, MP, Saumell, S, Voso, MT, Maciejewski, J, Acha, P, Valcarcel, D, Jerez, A, Montoro, MJ. Bone marrow alterations and clonal hematopoiesis in germline ETV6 mutation carriers without hematologic malignancy. BLOOD. 2025; 146DOI:10.1182/blood-2025-4997. PMID:. IF:23.100(Q1/1D).
03/11/2025
First-line therapy with rituximab vs. rituximab-CHOP in post-transplant monomorphic diffuse large B-cell lymphoma (DLBCL): Long-term real-world evidence from the spanish group of lymphoma (GELTAMO)
Ubieto, AJ, Alós, DG, Dominguez, SR, Magnano, L, Sánchez, S, Vicente, FD, Iacoboni, G, Losada, CM, Manso, RG, Browne, S, Izquierdo, AR, Baumann, T, Bacelar, AG, Santaella, MP, Prieto, PG, De Villambrosia, SG, Bastos-Oreiro, M, Hernandez, AC, De Miguel, LB, Sturla, AL, Abellan, PF, Vidaller, PJP, Amutio, E, Toimil, FS, Pardal, E, Micó, M, Prat, AM, De La Cruz, B, Huerga, S, Landwehr, M, Hernández, I, Andreu, R, De la Cruz, J, Barca, EG. First-line therapy with rituximab vs. rituximab-CHOP in post-transplant monomorphic diffuse large B-cell lymphoma (DLBCL): Long-term real-world evidence from the spanish group of lymphoma (GELTAMO). BLOOD. 2025; 146DOI:10.1182/blood-2025-3677. PMID:. IF:23.100(Q1/1D).
03/11/2025
Diagnostic evaluation methods and prognostic impact of FLT3-ITD microclones in Acute Myeloid Leukemia (AML): A retrospective multicenter study on behalf of the EHA AML-specialized working group (SWG)
Gurnari, C, Ottone, T, Piciocchi, A, Späth, D, Meid, A, Marsili, G, Fabiani, E, Romano, F, Pascale, MR, Chiusolo, P, Di Ianni, M, Sobas, M, Brunetti, L, Oñate, G, Infante, JB, Nanni, J, Vetro, C, Boada, M, Candoni, A, Sierra, J, Potter, N, Gilkes, A, Johnson, S, Thomas, I, Huntley, B, Russell, N, Dillon, R, Döhner, H, Döhner, K, Voso, MT. Diagnostic evaluation methods and prognostic impact of FLT3-ITD microclones in Acute Myeloid Leukemia (AML): A retrospective multicenter study on behalf of the EHA AML-specialized working group (SWG). BLOOD. 2025; 146DOI:10.1182/blood-2025-217. PMID:. IF:23.100(Q1/1D).